Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glipizide pharmacokinetics and effects on insulin and glucose in newly diagnosed type 2 diabetes
2006-007070-30Phase 2Active
- Sponsor
- Region Stockholm
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of glipizide in type 2 diabetes mellitus (T2DM), sponsored by Region Stockholm. Started May 2007; status: active.
02
Drugs
glipizide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-007070-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007070-30.